HEORStrategies conducts systematic literature reviews (SLRs) and compiles, analyzes, and synthesizes evidence from published studies to support new product-value frameworks. Our SLR development process is efficient and comprehensive. We follow established guidelines (e.g., PRISMA, STROBE, and MOOSE) and conduct SLRs in therapeutic areas that range from rare and autoimmune disease to cancers and more prevalent conditions. HEORStrategies and EpidStrategies, divisions of ToxStrategies LLC, are recognized in the industry as leaders in systematic literature reviews (SLRs).
- Our SLRs typically include meta-analyses, synthesizing evidence from published studies.
- We conduct pooled individual patient data (IPD) analyses to synthesize results from multiple epidemiological studies.
- We conduct indirect treatment comparisons and network meta-analyses to estimate relative treatment effects when head-to-head data are lacking.
- We conduct SLRs in a wide range of disease areas, from rare and ultra-rare to prevalent diseases.
- We disseminate our SLRs and meta-analyses in conference presentations and peer-reviewed publications.